Kidney transplant recipients who’ve never been exposed to the Epstein-Barr virus but receive organs from a donor who has been may develop a rare and aggressive cancer As many as 1,200 patients a year ...

Merck & Co has entered into a worldwide licensing deal with Opko Health’s ModeX Therapeutics unit for a vaccine candidate against Epstein-Barr virus (EBV) that could be worth up to $922.5 ...

An exanthem is any eruptive skin rash that may be associated with fever ... aminopenicillins are administered to patients with Epstein–Barr virus is a bright-red morbilliform eruption that ...

All-cause graft failure risk was higher for recipients of Epstein–Barr virus D-positive/R-negative kidneys. The Epstein–Barr virus D-positive/R-negative group had up to a 10-fold higher ...

Researchers at Yale University in a small, yet to be published study found that Covid vaccines were linked to a rare ...

In a small study, patients with the syndrome were more likely to experience reactivation of Epstein-Barr virus and high levels of a coronavirus protein. By Apoorva Mandavilli An estimated 15 ...

A positive antinuclear antibody was detected in 21% of the athletes, without any clinical evidence of autoimmune disorders. Evidence of Epstein-Barr virus reactivation was detected in 22% of the ...

Antiviral treatments strive to block a virus or halt its replication. However, viruses are ... An Unexpected Mechanism Regulates the Immune Response During Parasitic Infections Feb. 7, 2025 ...